Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine.
García-Grimshaw M, Michel-Chávez A, Vera-Zertuche JM, Galnares-Olalde JA, Hernández-Vanegas LE, Figueroa-Cucurachi M, Paredes-Ceballos O, Reyes-Terán G, Carbajal-Sandoval G, Ceballos-Liceaga SE, Arauz A, Valdés-Ferrer SI.
García-Grimshaw M, et al.
Clin Immunol. 2021 Sep;230:108818. doi: 10.1016/j.clim.2021.108818. Epub 2021 Aug 4.
Clin Immunol. 2021.
PMID: 34358692
Free PMC article.